Literature DB >> 14991399

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

Magdalena Figlerowicz1, Wojciech Sluzewski, Arleta Kowala-Piaskowska, Iwona Mozer-Lisewska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14991399     DOI： 10.1007/s00431-004-1418-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

Review 1.  Extracorporeal liver support with MARS in liver failure: has it a role in the treatment of severe alcoholic hepatitis?

Authors:  Philippe Ichai; Didier Samuel
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

2.  Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.

Authors:  Patrizia Farci; Rita Strazzera; Harvey J Alter; Stefania Farci; Daniela Degioannis; Alessandra Coiana; Giovanna Peddis; Francesco Usai; Giancarlo Serra; Luchino Chessa; Giacomo Diaz; Angelo Balestrieri; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.

Authors:  B Christensson; T Wiebe; A Akesson; A Widell
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

4.  Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

Authors:  Stefan Wirth; Thomas Lang; Stephan Gehring; Patrick Gerner
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

Review 6.  Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections.

Authors:  Magdalena Figlerowicz; Magdalena Alejska; Anna Kurzyńska-Kokorniak; Marek Figlerowicz
Journal:  Med Res Rev       Date:  2003-07       Impact factor: 12.944
  6 in total
  4 in total

Review 1.  Treatment of hepatitis C in children: a systematic review.

Authors:  Jia Hu; Karen Doucette; Lisa Hartling; Lisa Tjosvold; Joan Robinson
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

2.  Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy.

Authors:  Magdalena Figlerowicz; Paulina Jackowiak; Piotr Formanowicz; Paweł Kędziora; Magdalena Alejska; Nelli Malinowska; Jacek Błażewicz; Marek Figlerowicz
Journal:  Arch Virol       Date:  2010-09-15       Impact factor: 2.574

3.  IL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis C.

Authors:  Yan-Wei Zhong; Hong-Fei Zhang; Yan-Min Shi; Yong-Li Li; Fang Chu; Zhi-Qiang Xu; Da-Wei Chen; Yu Gan; Fu-Chuan Wang; Mei-Lei Gu; Yi Dong; Shi-Shu Zhu; Ce Shi; Hua-Hao Fan; Xiu-Chang Zhang; Min Zhang
Journal:  Int J Biol Sci       Date:  2016-10-25       Impact factor: 6.580

4.  Treatment Options for Hepatitis C Infection in Children.

Authors:  Aymin Delgado-Borrego; Maureen M. Jonas
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.